8
Oct
2024

Cristalia

Exhibitor at CPHI Milan 2024 stand 14D40, Finished Dosage Formulations
About Us

With 107 granted patents and 209 pending applications around the world, Cristália holds a leading position in sales of ANESTHETICS and allied products in Latin America. With 6 sites in Brazil and Argentina, Cristália exports ANTI-AIDS, PSYCHIATRIC, PAIN MANAGEMENT, ONCOLOGY, BIOTECHNOLOGY finish dosages and APIs to more than 30 countries.




  • BR
  • 2015
    On CPHI since
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14D40, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • (R)-(+)-bupivacaine hydrochloride

    Product (R)-(+)-bupivacaine hydrochloride

    This product belongs to a group of medicines indicated for Local Anesthetic. Contact us for more information.
  • (R)-(+)-bupivacaine hydrochloride

    Product (R)-(+)-bupivacaine hydrochloride

    It belongs to a group of medicines indicated for Antipsychotic. Contact us for more information.
  • (S)-(+)-Ketamine hydrochloride

    Product (S)-(+)-Ketamine hydrochloride

    It belongs to a group of medicines indicated for Antipsychotic. Contact us for more information.
  • (S)-(+)-Ketamine hydrochloride

    Product (S)-(+)-Ketamine hydrochloride

    The product belongs to a group of medicines indicated for Anesthetic. Contact us for more information.
  • Alfast® 0.544 MG/ML (7.500 AMPS)

    Product Alfast® 0.544 MG/ML (7.500 AMPS)

    This product is indicated for Narcotic Analgesic. Generic name: ALFENTANIL HYDROCHLORIDE. Presentation: 10AMP X 5 ML. Batch size: 93.000 AMPS. Indication: As a narcotic analgesic, It is indicated for general anesthesia in surgical procedures of short and long terms. It is also recommended for outpatient su...